^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MI Tumor Seek™

    Company:
    Caris Life Sci
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    MI Tumor Seek™ (592-Gene NGS Panel) is a Next-Generation Sequencing (NGS)-based tumor profiling service that includes Whole Exome Sequencing (WES) analysis of DNA for mutations, copy number alterations, insertions/deletions, genomic signatures (MSI, TMB), and Whole Transcriptome Sequencing analysis for RNA fusions and variant transcripts.
    Cancer:
    Solid Tumor
    Gene:
    ABL1 (ABL proto-oncogene 1), ALK (Anaplastic lymphoma kinase), BCL2 (B-cell CLL/lymphoma 2), MSI (Microsatellite instability), POLD1 (DNA Polymerase Delta 1), TMB (Tumor Mutational Burden)
    Method:
    Next-Generation Sequencing (NGS)